ZTOX

Rubfila International Files Q4/FY 2026 Results Publication with BSE

Rubfila International has filed a regulatory disclosure with BSE regarding newspaper publication of its Q4 and full-year financial results ended March 31, 2026, in Hindu Businessline and Kerala Kaumudi.

POKARNA

Pokarna Board Recommends Final Dividend for FY 2025-26

Pokarna Limited (POKARNA) board recommends final dividend for FY 2025-26. The proposal awaits shareholder approval at the company's annual general meeting.

POKARNA

Pokarna Board Recommends Final Dividend for FY 2025-26

Pokarna Limited has announced that its Board of Directors has recommended a final dividend for the financial year 2025-26, subject to shareholder approval.

POKARNA

Pokarna Board Recommends Final Dividend for FY 2025-26

Pokarna Limited's board of directors has recommended a final dividend for the financial year 2025-26, according to a BSE corporate announcement.

Rubfila International Discloses FY2026 Financial Results Publication

Rubfila International has disclosed newspaper publication of its quarterly and annual financial results for the period ending March 31, 2026.

Rubfila International Publishes Q4/FY2026 Financial Results via BSE Filing

Rubfila International has filed its Q4/FY2026 financial results with BSE, meeting SEBI disclosure requirements through newspaper publications in Hindu Businessline and Kerala Kaumudi.

Rubfila International Publishes FY2026 Financial Results in Newspapers

Rubfila International has published its Q4 and FY2026 financial results through newspaper advertisements as per SEBI disclosure requirements.

Deep Health AI India Delays FY26 Financial Results Approval

Deep Health AI India Limited has deferred consideration of its FY2026 audited standalone and consolidated financial results to May 29, 2026, according to a BSE filing.

Deep Health AI India Delays FY2026 Financial Results Approval to May 29

Deep Health AI India Limited has deferred the consideration and approval of its FY2026 audited standalone and consolidated financial results to May 29, 2026, after a board meeting held on May 27.

Deep Health AI India Defers FY2026 Financial Results to May 29

Deep Health AI India Limited's board has deferred consideration of its FY2026 audited standalone and consolidated financial results to May 29, 2026.

Deep Health AI India Defers FY26 Financial Results to May 29

Deep Health AI India Limited has deferred consideration of its audited standalone and consolidated financial results for FY26 from May 27 to May 29, 2026. The company filed a revised board meeting outcome correcting typographical errors from its earlier submission.

WEIZMANIND

Weizmann Limited Recommends Rs 0.50 Final Dividend for FY26

Weizmann Limited's board recommends Rs 0.50 per share final dividend for FY26 following May 28 board meeting. Shareholder approval pending for payout.

WEIZMANIND